June 2016 CAC Update
There was only 1 proposed LCD policy discussed at this meeting that may have some relevance to Rheumatologists:
DL35062 Biomarkers Overview
Click the link for more infomation on this proposed LCD policy.
Other topics of interest:
DL35062 Biomarkers Overview
Click the link for more infomation on this proposed LCD policy.
Other topics of interest:
- Germ line testing for DMD, Dystrophin, in Duchene/Becker Muscular Dystrophy is not covered
- Cytochrome P 450 testing:
- CYP2C19 (Plavix metabolism) is only covered with Acute coronary syndrome with planned PCI
- CYP2D6 (tricyclic antidepressants metabolism) can be ordered only if Amitriptyline or Nortriptyline are prescribed to treat depression.